Fresenius Kabi AG

Fresenius Kabi AG is a global healthcare company that specializes in lifesaving medicines and technologies for infusion, transfusion, and clinical nutrition. The company offers a comprehensive range of I.V. generic drugs, infusion therapies, and clinical nutrition products as well as the devices for administering these products. Fresenius Kabi’s products and services are used to help care for critically and chronically ill patients. The company is also a leader in the field of biosimilars, which are biopharmaceutical drugs designed to have active properties similar to those of drugs that have previously been licensed. With a strong commitment to quality and innovation, the company continuously invests in research and development to bring new and improved therapies to market. The company operates in over 100 countries and has a workforce dedicated to improving patient outcomes and enhancing the quality of life for patients around the world. Sustainability and corporate responsibility are also key components of the company’s mission, with initiatives aimed at reducing environmental impact and supporting community health programs.